p53 Protein in Bladder Cancer
Author Information
Author(s): Y. Soinil, T. Turpeenniemi-Hujanen, D. Kamell, H. Autio-Harmainen, J. Risteli, L. Risteli, K. Nuorval, P. Pdikk6, K. Vahakangas
Primary Institution: University of Oulu
Hypothesis
Does p53 immunohistochemistry correlate with disease progression in bladder cancer?
Conclusion
The study found a strong association between p53 positivity and higher grades of bladder cancer, suggesting that p53 mutations may be linked to aggressive tumor characteristics.
Supporting Evidence
- 50% of transitional cell carcinomas showed p53 positivity.
- 78% of dysplasias were p53 positive.
- Significantly more p53 positive cases were found in grade II-III tumors compared to grade I tumors.
Takeaway
This study looked at a protein called p53 in bladder cancer and found that more aggressive cancers had more of this protein, which might help doctors understand how serious the cancer is.
Methodology
The study analyzed p53 immunohistochemistry in 42 transitional cell carcinomas and 14 dysplasias, using a polyclonal antibody.
Limitations
The study is limited by its retrospective design and the small sample size of certain tumor grades.
Participant Demographics
Participants included patients with transitional cell carcinoma and dysplasia of the urinary bladder from Oulu University Central Hospital.
Statistical Information
P-Value
0.004
Statistical Significance
p=0.004
Want to read the original?
Access the complete publication on the publisher's website